These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Effective chemotherapy for hormone-refractory prostate cancer: docetaxel-prednisone]. Batman E; de Wit R Ned Tijdschr Geneeskd; 2005 Oct; 149(44):2442-5. PubMed ID: 16285357 [TBL] [Abstract][Full Text] [Related]
10. New standards in the chemotherapy of metastatic hormone-refractory prostate cancer. Sava T; Basso U; Porcaro A; Cetto GL Expert Rev Anticancer Ther; 2005 Feb; 5(1):53-62. PubMed ID: 15757438 [TBL] [Abstract][Full Text] [Related]
11. Current studies with docetaxel in hormone-refractory prostate cancer: selected presentations from the 27th European Society for Medical Oncology Congress, 2002. DeGrendele H Clin Prostate Cancer; 2003 Mar; 1(4):212-4. PubMed ID: 15040878 [No Abstract] [Full Text] [Related]
13. Editorial comment on: combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study. Oudard S Eur Urol; 2008 Nov; 54(5):1094-6. PubMed ID: 18276066 [No Abstract] [Full Text] [Related]
14. Current chemotherapeutic approaches for androgen-independent prostate cancer. Rumohr JA; Chang SS Curr Opin Investig Drugs; 2006 Jun; 7(6):529-33. PubMed ID: 16784023 [TBL] [Abstract][Full Text] [Related]
15. Cabazitaxel in prostate cancer: stretching a string. Dorff TB; Quinn DI Lancet; 2010 Oct; 376(9747):1119-20. PubMed ID: 20888974 [No Abstract] [Full Text] [Related]
16. The current role of chemotherapy in metastatic hormone-refractory prostate cancer. Petrylak DP Urology; 2005 May; 65(5 Suppl):3-7; discussion 7-8. PubMed ID: 15885271 [TBL] [Abstract][Full Text] [Related]
17. Recent docetaxel studies establish a new standard of care in hormone refractory prostate cancer. Van Poppel H Can J Urol; 2005 Feb; 12 Suppl 1():81-5. PubMed ID: 15780173 [TBL] [Abstract][Full Text] [Related]
18. [Hormonoresistant metastatic prostate cancer: analysis of two phase III clinical studies]. Ferrero JM Bull Cancer; 2005 May; 92(5):425-7. PubMed ID: 15932803 [TBL] [Abstract][Full Text] [Related]
19. Clinical trials in metastatic prostate cancer--has there been real progress in the past decade? Bhandari MS; Petrylak DP; Hussain M Eur J Cancer; 2005 Apr; 41(6):941-53. PubMed ID: 15808960 [TBL] [Abstract][Full Text] [Related]
20. Update in the management of patients with hormone-refractory prostate cancer. Moore CN; George DJ Curr Opin Urol; 2005 May; 15(3):157-62. PubMed ID: 15815191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]